English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [2093]
News [6483]
Articles [133]
Editorials [5]
Conferences [171]
elearning [10]
Mouse models show tailored immunotherapy to be effective
Mouse models show tailored immunotherapy to be effective
£5M stratified medicine programme launced to personalise care for bowel cancer patients
£5M stratified medicine programme launced to personalise care for bowel cancer patients
AACR 2015: Olaparib and investigational PI3K inhibitor BKM120 combination active against ovarian and breast cancer subtypes
AACR 2015: Olaparib and investigational PI3K inhibitor BKM120 combination active against ovarian and breast cancer...
AACR 2015: Black women found to have denser breast tissue than white women
AACR 2015: Black women found to have denser breast tissue than white women
AACR 2015: Dual mTOR inhibitor-fulvestrant combo feasible, with clinical benefit for advanced breast cancer patients
AACR 2015: Dual mTOR inhibitor-fulvestrant combo feasible, with clinical benefit for advanced breast cancer...
AACR 2015: Real-world targeted treatment based on whole genome sequencing difficult in pancreatic cancer
AACR 2015: Real-world targeted treatment based on whole genome sequencing difficult in pancreatic cancer
AACR 2015: 'Liquid biopsy' may help earlier detection of lung cancer treatment resistance
AACR 2015: 'Liquid biopsy' may help earlier detection of lung cancer treatment resistance
AACR 2015: Combining two investigational immunotherapy drugs safe, with early signs of effectiveness
AACR 2015: Combining two investigational immunotherapy drugs safe, with early signs of effectiveness
AARC 2015: Combining Chk1 inhibition with standard dose gemcitabine may be safe and effective
AARC 2015: Combining Chk1 inhibition with standard dose gemcitabine may be safe and effective
AACR 2015: Pembrolizumab promising for lung cancer, clinical outcomes correlate with biomarker
AACR 2015: Pembrolizumab promising for lung cancer, clinical outcomes correlate with biomarker
<1...570571572573574...649>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top